209 related articles for article (PubMed ID: 5438009)
1. Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium.
Bircher J; Haemmerli UP; Williams R
Gastroenterology; 1970 Apr; 58(4):595-7. PubMed ID: 5438009
[No Abstract] [Full Text] [Related]
2. [Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].
Eisenburg J; Krumpoch B; Grunst J; Weinzierl M; Munte A; Schmidt S; Magerl W; Schauer S
Fortschr Med; 1972 Aug; 90(24):837-48. PubMed ID: 4639347
[No Abstract] [Full Text] [Related]
3. Lactulose treatment of hepatic encephalopathy: effects on carbohydrate metabolism and colonic hydrogen ion concentration.
Trey C; Brown H; Goransky L; McDermott WV
Surg Forum; 1970; 21():355-6. PubMed ID: 4936990
[No Abstract] [Full Text] [Related]
4. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
Elkington SG; Floch MH; Conn HO
N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
[No Abstract] [Full Text] [Related]
5. [Treatment of chronic portal-systemic encephalopathy with lactulose (synthetic disaccharide: one molecule of galactose and one of fructose)].
Cassi E; Sala E; Beretta R; Colombo A; Cova L; Ezechieli S; Malacco E; Massarotti G; Pagani C
Clin Ter; 1972 Dec; 63(6):531-56. PubMed ID: 4656204
[No Abstract] [Full Text] [Related]
6. [On the diagnostic value of the brain wave pattern in hepato-portal encephalopathy: together with a clinical-statistical contribution to the question of neurologic and psychic changes in liver cirrhosis and portacaval anastomosis operations].
Penin H
Fortschr Neurol Psychiatr Grenzgeb; 1967 Apr; 35(4):174-234. PubMed ID: 5182416
[No Abstract] [Full Text] [Related]
7. Milk protein in the treatment of chronic portasystemic encephalopathy. A long-term study of therapeutic measures in a patient with chronic porta-systemic encephalopathy.
Van Der Zwan JC; Gips CH; Qué GS; Boonstra S
Neth J Med; 1974; 17(2):42-9. PubMed ID: 4839373
[No Abstract] [Full Text] [Related]
8. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
Germain L; Frexinos J; Louis A; Ribet A
Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594756
[No Abstract] [Full Text] [Related]
9. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
Germain L; Frexinos J; Louis A; Ribet A
Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594755
[No Abstract] [Full Text] [Related]
10. Lactulose treatment of chronic hepatoportal encephalopathy. A clinical and electroencephalographic study.
Rorsman G; Sulg I
Acta Med Scand; 1970 May; 187(5):337-46. PubMed ID: 5526951
[No Abstract] [Full Text] [Related]
11. [1st use of lactitol in the treatment of porto-systemic encephalopathy].
Bircher J; Bührer M; Franz K; van Velthuijsen JA
Schweiz Med Wochenschr; 1982 Sep; 112(38):1306-7. PubMed ID: 7134954
[TBL] [Abstract][Full Text] [Related]
12. [Lactulose in the treatment of chronic portosystemic encephalopathies].
Seidlová V
Cesk Gastroenterol Vyz; 1974 Apr; 28(3):201-7. PubMed ID: 4447986
[No Abstract] [Full Text] [Related]
13. [Contribution to the treatment of portal systemic encephalopathy (author's transl)].
Blahníková L; Horký J; Pechar J; Honzák R; Vosmík J
Cesk Gastroenterol Vyz; 1978 Dec; 32(8):486-93. PubMed ID: 737756
[No Abstract] [Full Text] [Related]
14. [Clinical and physiopathological study of hepatic encephalopathy].
Spatz R; Kollmannsgerger A
Minerva Med; 1972 Feb; 63(12):721-6. PubMed ID: 5012554
[No Abstract] [Full Text] [Related]
15. [The so called hepatic encephalopathy. Pathophysiology and diagnosis].
Spatz R; Kollmannsberger A
Munch Med Wochenschr; 1971 Sep; 113(39):1250-4. PubMed ID: 5171156
[No Abstract] [Full Text] [Related]
16. Some concepts on ammonia, porta-systemic shunts, and encephalopathy.
Gips CH; Hindfelt B; Holmin T; Kardel T
Scand J Gastroenterol; 1973; 8(5):385-8. PubMed ID: 4584758
[No Abstract] [Full Text] [Related]
17. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
Paris J; Merveille P; Molimard R
Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
[No Abstract] [Full Text] [Related]
18. [Effects of arginine malate in experimental and clinical hyperammonemia].
Szãm I; Szentner J; Hegedüs-Wein I; Vass A
Int J Clin Pharmacol; 1972 Aug; 6(3):260-5. PubMed ID: 4648469
[No Abstract] [Full Text] [Related]
19. Lactulose treatment of hepatic encephalopathy in outpatients.
Brown H; Trey C; McDermott WV
Arch Surg; 1971 Jan; 102(1):25-7. PubMed ID: 5538764
[No Abstract] [Full Text] [Related]
20. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM
Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591
[No Abstract] [Full Text] [Related]
[Next] [New Search]
